These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 28051228

  • 41. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
    Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A.
    Kidney Int; 2012 Nov; 82(10):1130-5. PubMed ID: 22763815
    [Abstract] [Full Text] [Related]

  • 42. Heparanase activity is dysregulated in children with steroid-sensitive nephrotic syndrome.
    Holt RC, Webb NJ, Ralph S, Davies J, Short CD, Brenchley PE.
    Kidney Int; 2005 Jan; 67(1):122-9. PubMed ID: 15610235
    [Abstract] [Full Text] [Related]

  • 43. [Idiopathic Nephrotic Syndrome: recommendations of the Nephrology Branch of the Chilean Society of Pediatrics. Part One].
    Hevia P, Nazal V, Rosati MP, Quiroz L, Alarcón C, Márquez S, Cuevas K, En Representación de la Rama de Nefrología de la Sociedad Chilena de Pediatría.
    Rev Chil Pediatr; 2015 Jan; 86(4):291-8. PubMed ID: 26362970
    [Abstract] [Full Text] [Related]

  • 44. Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
    Fujinaga S, Hirano D, Mizutani A, Sakuraya K, Yamada A, Sakurai S, Shimizu T.
    Clin Exp Nephrol; 2017 Aug; 21(4):671-676. PubMed ID: 27558467
    [Abstract] [Full Text] [Related]

  • 45. Cyclosporine in the treatment of childhood idiopathic steroid resistant nephrotic syndrome: a single centre experience in Nigeria.
    Ladapo TA, Esezobor CI, Lesi FE.
    Pan Afr Med J; 2016 Aug; 25():258. PubMed ID: 28293374
    [Abstract] [Full Text] [Related]

  • 46. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children.
    Larkins N, Kim S, Craig J, Hodson E.
    Arch Dis Child; 2016 Apr; 101(4):404-8. PubMed ID: 26289063
    [Abstract] [Full Text] [Related]

  • 47. [Immunity and immunosuppression in childhood idiopathic nephrotic syndrome].
    Frange P, Frey MA, Deschênes G.
    Arch Pediatr; 2005 Mar; 12(3):305-15. PubMed ID: 15734130
    [Abstract] [Full Text] [Related]

  • 48. Rituximab for Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome in Adults: A Retrospective, Multicenter Study in Spain.
    DaSilva I, Huerta A, Quintana L, Redondo B, Iglesias E, Draibe J, Praga M, Ballarín J, Díaz-Encarnación M, Spanish Group for the Study of Glomerular Diseases (GLOSEN).
    BioDrugs; 2017 Jun; 31(3):239-249. PubMed ID: 28534103
    [Abstract] [Full Text] [Related]

  • 49. Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome.
    Sinha A, Gupta A, Kalaivani M, Hari P, Dinda AK, Bagga A.
    Kidney Int; 2017 Jul; 92(1):248-257. PubMed ID: 28318625
    [Abstract] [Full Text] [Related]

  • 50. Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort.
    Trautmann A, Bodria M, Ozaltin F, Gheisari A, Melk A, Azocar M, Anarat A, Caliskan S, Emma F, Gellermann J, Oh J, Baskin E, Ksiazek J, Remuzzi G, Erdogan O, Akman S, Dusek J, Davitaia T, Özkaya O, Papachristou F, Firszt-Adamczyk A, Urasinski T, Testa S, Krmar RT, Hyla-Klekot L, Pasini A, Özcakar ZB, Sallay P, Cakar N, Galanti M, Terzic J, Aoun B, Caldas Afonso A, Szymanik-Grzelak H, Lipska BS, Schnaidt S, Schaefer F, PodoNet Consortium.
    Clin J Am Soc Nephrol; 2015 Apr 07; 10(4):592-600. PubMed ID: 25635037
    [Abstract] [Full Text] [Related]

  • 51. Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directions.
    Moudgil A, Bagga A, Jordan SC.
    Pediatr Nephrol; 2005 Oct 07; 20(10):1376-81. PubMed ID: 15977023
    [Abstract] [Full Text] [Related]

  • 52. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol.
    Hibino S, Uemura O, Nagai T, Yamakawa S, Iwata N, Ito H, Nakano M, Tanaka K.
    Pediatr Int; 2015 Oct 07; 57(1):85-91. PubMed ID: 25225083
    [Abstract] [Full Text] [Related]

  • 53. Predictive risk factors of steroid dependent nephrotic syndrome in children.
    Abdel-Hafez MA, Abou-El-Hana NM, Erfan AA, El-Gamasy M, Abdel-Nabi H.
    J Nephropathol; 2017 Jul 07; 6(3):180-186. PubMed ID: 28975099
    [Abstract] [Full Text] [Related]

  • 54. The role of soluble immune response suppressor lymphokine in the prediction of steroid responsiveness in idiopathic nephrotic syndrome.
    Cheng IK, Jones BM, Chan PC, Chan MK.
    Clin Nephrol; 1989 Oct 07; 32(4):168-72. PubMed ID: 2805458
    [Abstract] [Full Text] [Related]

  • 55. Long-term outcome of the difficult nephrotic syndrome in children.
    Al Salloum AA, Muthanna A, Bassrawi R, Al Shehab AA, Al Ibrahim A, Islam MZ, Al Hasan K.
    Saudi J Kidney Dis Transpl; 2012 Sep 07; 23(5):965-72. PubMed ID: 22982908
    [Abstract] [Full Text] [Related]

  • 56. Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie.
    Lancet; 1988 Feb 20; 1(8582):380-3. PubMed ID: 2893190
    [Abstract] [Full Text] [Related]

  • 57. [Long-term effects of cyclosporine A in children with steroid-resistant idiopathic nephrotic syndrome and outcomes of the patients].
    Cao Q, Huang WY, Xu H, Zhou LJ.
    Zhonghua Er Ke Za Zhi; 2008 Sep 20; 46(9):698-701. PubMed ID: 19099862
    [Abstract] [Full Text] [Related]

  • 58. Can we predict relapses in children with idiopathic steroid-sensitive nephrotic syndrome?
    Mishra OP, Abhinay A, Mishra RN, Prasad R, Pohl M.
    J Trop Pediatr; 2013 Oct 20; 59(5):343-9. PubMed ID: 23619602
    [Abstract] [Full Text] [Related]

  • 59. [Clinical application of tacrolimus with low-dose prednisone in 21 children with steroid-resistant nephrotic syndrome].
    Yao SH, Mao JH, Xia YH, Wang DY, Chen YF, Fang CQ, Liu AM, Du LZ.
    Zhonghua Er Ke Za Zhi; 2011 Nov 20; 49(11):825-8. PubMed ID: 22336304
    [Abstract] [Full Text] [Related]

  • 60. Steroid resistance in childhood nephrotic syndrome.
    Berns JS, Siegel NJ.
    Kidney Int; 2006 May 20; 69(10):1915-6. PubMed ID: 16688194
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.